October 30, 2018

Lilly Endowment Elects Lechleiter to its Board of Directors

John Lechleiter has been elected to serve on the Board of Directors of Lilly Endowment Inc., effective December 1, 2018. Lechleiter is the former chairman, president and chief executive officer...

October 11, 2018

Life Sciences Special Supplement to Indianapolis Monthly Magazine - October 2018

Learn about groundbreaking research at the Indiana Biosciences Research Institute (IBRI) on diabetes and healthcare big data, and how Roche Diagnostics is harnessing patient data to transform healthcare. See how...

October 01, 2018

News update from IBRI

This is a test of the News function on the website....

September 14, 2018

New Lilly Diabetes Center of Excellence Established at the Indiana Biosciences Research Institute

INDIANAPOLIS, September 13, 2018 - Eli Lilly and Company (NYSE: LLY) and the Indiana Biosciences Research Institute (IBRI), in collaboration with Indiana University School of Medicine, have created the Lilly...

September 13, 2018

Veteran entrepreneurial leader named Purdue Research Foundation’s chief innovation and collaboration officer

WEST LAFAYETTE, Ind. -- Purdue University President Mitch Daniels and Purdue Research Foundation President Brian Edelman have jointly announced the appointment of David Broecker as the foundation's chief innovation and...

June 07, 2018

Purdue University expands partnership with Indiana Biosciences Research Institute

Purdue University and the Indiana Biosciences Research Institute (IBRI) have entered into a strategic alliance agreement that allows for seamless research interactions among researchers at both institutions. The governance...

May 29, 2018

Indiana Biosciences Research Institute Names Vice President for Advancement

The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Stephanie Grinage as vice president for Advancement. As IBRI’s top development officer, she will serve as the primary strategic...

May 16, 2018

Indiana Biosciences Research Institute names executive director of engagement, communications and external affairs

The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Mark E. Craft as executive director of engagement, communications and external affairs, effective April 23, 2018. In this role,...

April 30, 2018

Zorion Medical Opens New Lab

Zorion Medical, Inc. has leased lab and production space in Indianapolis to jumpstart the development and clinical scale manufacturing of its fully absorbable medical device technology. The company is the...

April 20, 2018

John C. Lechleiter appointed to Indiana Biosciences Research Institute board of directors

The Indiana Biosciences Research Institute (IBRI) announces former Eli Lilly and Company chairman, president and CEO John C. Lechleiter, Ph.D., has joined its board of directors. Dr. Lechleiter retired from...

First ... 6 7 8 9 10  ... Last 
2019 Annual Report cover

The IBRI 2019 Annual Report is now available. The report theme is “Catalyze, Complement, Connect,” which correlates with the IBRI's goals to seek solutions for health problems, enhance the Indiana life sciences ecosystem, and expedite solutions for the most pressing health issues.